The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Pruritus Therapeutics Market Over The 2026–2030 Period?
The pruritus therapeutics market size has seen substantial growth recently. It is set to expand from $12.38 billion in 2025 to $13.08 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.6%. This historical development can be ascribed to several factors, including the increasing occurrence of inflammatory skin conditions, the greater application of corticosteroids and antihistamines, an uplift in dermatology research investment, the broadened scope of hospital and clinic infrastructures, and the early integration of topical therapeutic approaches.
The pruritus therapeutics market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $16.88 billion, demonstrating a compound annual growth rate (CAGR) of 6.6%. This projected increase throughout the forecast period stems from various factors, including progress in genomics and precision medicine, the emergence of new immunosuppressants, the proliferation of digital health and remote dermatology solutions, the rising availability of over-the-counter (OTC) pruritus products, and a heightened emphasis on managing chronic skin diseases. Key developments anticipated during this timeframe encompass individualized pruritus treatment methods, a greater emphasis on anti-inflammatory therapies, the development of topical formulations and advanced delivery systems, the broadening availability of over-the-counter (OTC) pruritus products, and an escalating recognition of chronic skin conditions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp
What Underlying Factors Are Accelerating The Growth Of The Pruritus Therapeutics Market?
The increasing prevalence of dermatological disorders is anticipated to propel the expansion of the pruritus therapeutics market going forward. These disorders encompass conditions affecting the skin, hair, nails, and mucous membranes, ranging from common issues like acne and eczema to more severe ailments such as skin cancer and fungal infections. The underlying cause of itching typically guides the selection of pruritus treatments for these dermatological illnesses, which may include topical applications, emollients and moisturizers, immunosuppressant medications, and anti-itch medications. For example, in January 2024, the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, projected 108,270 reported cases of skin cancer, representing a 3.2% increase from the 104,930 cases documented in 2023. Consequently, the rising incidence of dermatological disorders is a key factor driving the growth of the pruritus therapeutics market.
How Is The Pruritus Therapeutics Market Segmented Across Key Categories?
The pruritus therapeutics market covered in this report is segmented –
1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies
Which Upcoming Trends Are Expected To Influence The Pruritus Therapeutics Market?
Leading companies operating in the pruritus therapeutics market are directing their attention towards developing innovative biologic treatments, such as monoclonal antibody therapies, to effectively target and alleviate itching related to conditions including atopic dermatitis and prurigo nodularis. Monoclonal antibody treatment employs laboratory-produced molecules specifically engineered to identify and act upon certain proteins in the body, which are typically involved in disease processes. For instance, in June 2024, Maruho Co., Ltd., a Japan-based pharmaceutical company, launched Mitchga Subcutaneous Injection (30mg vials) in Japan. This product is indicated for the treatment of pruritus linked to atopic dermatitis in children (ages 6-13) and prurigo nodularis in adults and adolescents (ages ≥13) when other treatments have proven ineffective. The product contains nemolizumab, a humanized monoclonal antibody designed to target the interleukin-31 (IL-31) receptor. By inhibiting IL-31, the drug aims to reduce itching and improve the quality of life for patients experiencing these conditions.
Who Are The Dominant Players Shaping The Pruritus Therapeutics Market Landscape?
Major companies operating in the pruritus therapeutics market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Trevi Therapeutics Inc., AbbVie Biopharmaceuticals, Amgen Inc., Allergan plc, Horizon Therapeutics plc, Kyowa Kirin Co. Ltd., Dermira Inc., Pfizer Consumer Healthcare
Read the full pruritus therapeutics market report here:
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report
Which Region Is Projected To Dominate The Pruritus Therapeutics Market During The Forecast Period?
North America was the largest region in the pruritus treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pruritus Therapeutics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp
Browse Through More Reports Similar to the Global Pruritus Therapeutics Market 2026, By The Business Research Company
Pruritus Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report
Pruritus Therapeutic Market Report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report
Pertussis Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model